Staphylococcus via an interaction with the ELR+ CXC chemokine ENA-78 is associated with BOS

American Journal of Transplantation

Volumn 15, Issue 3, 2015, Pages 792-799

  Gregson, Aric L ^a   Wang, X ^a   Injean, P ^a   Weigt, S S ^a   Shino, M ^a   Sayah, D ^a   DerHovanessian, A ^a   Lynch, J P ^a   Ross, D J ^a   Saggar, R ^a   Ardehali, A ^b   Li, G ^c   Elashoff, R ^c   Belperio, J A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bacterial; bronchiolitis obliterans (BOS); chemokines chemokine receptors; clinical research; immune regulation; infection and infectious agents; infectious disease; lung transplantation; practice; pulmonology; rejection: chronic; science; translational research

Indexed keywords

EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; ALPHA CHEMOKINE;

ARTICLE; ASPERGILLUS; BRONCHIOLITIS OBLITERANS; HUMAN; LUNG GRAFT REJECTION; LUNG LAVAGE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; PSEUDOMONAS; PSEUDOMONAS PNEUMONIA; RISK FACTOR; STAPHYLOCOCCUS AUREUS; SURVIVAL RATE; BRONCHOALVEOLAR LAVAGE FLUID; METABOLISM; MICROBIOLOGY; PATHOGENICITY; TREATMENT OUTCOME;

BRONCHIOLITIS OBLITERANS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINE CXCL5; CHEMOKINES, CXC; HUMANS; LUNG TRANSPLANTATION; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 84924018148     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13029     Document Type: Article

References (30)

1. Valentine VG, Gupta MR, Walker JE, et al. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome. J Heart Lung Transplant 2009; 28: 163-169.
2. Weigt SS, Elashoff RM, Huang C, et al. Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome. Am J Transplant 2009; 9: 1903-1911.
3. Weigt SS, Elashoff RM, Keane MP, et al. Altered levels of CC chemokines during pulmonary CMV predict BOS and mortality post-lung transplantation. Am J Transplant 2008; 8: 1512-1522.
4. Weigt SS, Derhovanessian A, Liao E, et al. CXCR3 chemokine ligands during respiratory viral infections predict lung allograft dysfunction. Am J Transplant 2012; 12: 477-484.
5. Parada MT, Alba A, Sepulveda C., Early and late infections in lung transplantation patients. Transplant Proc 2010; 42: 333-335.
6. Aguilar-Guisado M, Givalda J, Ussetti P, et al. Pneumonia after lung transplantation in the RESITRA Cohort: A multicenter prospective study. Am J Transplant 2007; 7: 1989-1996.
7. Horvath J, Dummer S, Loyd J, Walker B, Merrill WH, Frist WH., Infection in the transplanted and native lung after single lung transplantation. Chest 1993; 104: 681-685.
8. Valentine VG, Bonvillain RW, Gupta MR, et al. Infections in lung allograft recipients: Ganciclovir era. J Heart Lung Transplant 2008; 27: 528-535.
9. Zeglen S, Wojarski J, Wozniak-Grygiel E, et al. Frequency of Pseudomonas aeruginosa colonizations/infections in lung transplant recipients. Transplant Proc 2009; 41: 3222-3224.
10. Campos S, Caramori M, Teixeira R, et al. Bacterial and fungal pneumonias after lung transplantation. Transplant Proc 2008; 40: 822-824.
11. Deusch E, End A, Grimm M, Graninger W, Klepetko W, Wolner E., Early bacterial infections in lung transplant recipients. Chest 1993; 104: 1412-1416.
12. Gupta MR, Valentine VG, Walker JE, et al. Clinical spectrum of gram-positive infections in lung transplantation. Transpl Infect Dis 2009; 11: 424-431.
13. Shields RK, Clancy CJ, Minces LR, et al. Staphylococcus aureus infections in the early period after lung transplantation: Epidemiology, risk factors, and outcomes. J Heart Lung Transplant 2012; 31: 1199-1206.
14. Vos R, Vanaudenaerde BM, Dupont LJ, Raemdonck DEV, Verleden GM., Transient airway colonization is associated with airway inflammation after lung transplantation. Am J Transplant 2007; 7: 1278-1287.
15. Gregson AL, Wang X, Weigt SS, et al. Interaction between pseudomonas and CXC chemokines increases risk of BOS and death in lung transplantation. Am J Respir Crit Care Med 2013; 187: 518-526.
16. Gregson AL, Hoji A, Palchevskiy V, et al. Protection against bronchiolitis obliterans syndrome is associated with allograft CCR7+ CD45RA- T regulatory cells. PloS ONE 2010; 5: e11354.
17. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007; 26: 1229-1242.
18. Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant 1993; 12: 713-716.
19. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297-310.
20. Belperio JA, Keane MP, Burdick MD, et al. Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome. J Clin Invest 2005; 115: 1150-1162.
21. Andersen PK, Gill RD., Cox's regression model for counting process: A large sample study. Ann Stat 1982; 10: 1100-1120.
22. Cox DR,. Regression models and life-tables. J Roy Stat Soc B Met 1972; 34: 187-220.
23. Institute SAS. SAS/STAT User's Guide. Version 9.2. Cary, NC: SAS Institute, 2005.
24. R Development Core Team. R: A Language and Environment for Statistical Computing, 2009. Available at: http://www.R-project.org. Accessed January 16, 2015.
25. Botha P, Archer L, Anderson RL, et al. Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome. Transplantation 2008; 85: 771-774.
26. Vos R, Vanaudenaerde BM, De Vleeschauwer SI, Van Raemdonck DE, Dupont LJ, Verleden GM., De novo or persistent pseudomonal airway colonization after lung transplantation: Importance for bronchiolitis obliterans syndrome ? Transplantation 2008; 86: 624-625.
27. Gottlieb J, Mattner F, Weissbrodt H, et al. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis. Respir Med 2009; 103: 743-749.
28. Hopkins PM, Aboyoun CL, Chhajed PN, et al. Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis. Am J Respir Crit Care 2004; 170: 1022-1026.
29. Malinis MF, Mawhorter SD, Jain A, Shrestha NK, Avery RK, van Duin D., Staphylococcus aureus bacteremia in solid organ transplant recipients: Evidence for improved survival when compared with nontransplant patients. Transplantation 2012; 93: 1045-1050.
30. Rosenbluth DB, Wilson K, Ferkol T, Schuster DP., Lung function decline in cystic fibrosis patients and timing for lung transplantation referral. Chest 2004; 126: 412-419.